Edesa Biotech reports a Schedule 13G showing Rubric Capital Management and David Rosen beneficially own 687,500 Common Shares (7.74%). The filing states the holdings reflect 8,885,719 Common Shares outstanding as of March 30, 2026. The reported position is held by Rubric Funds with shared voting and dispositive power of 687,500 shares, and Rubric Long Term Opportunities Offshore Master Fund, LP is identified as having the right to receive dividends or sale proceeds on more than 5% of the class.
Positive
None.
Negative
None.
Insights
Passive >5% disclosure of common stock by an investment adviser.
The Schedule 13G reports 687,500 shares or 7.74% of Common Shares based on 8,885,719 outstanding as of March 30, 2026. The filing attributes shared voting and dispositive power to Rubric Capital and names a fund with rights to dividends or proceeds.
This is a passive ownership disclosure under securities rules and does not indicate an active change in control. Subsequent filings would show any change in voting intent or percent ownership.
Key Figures
Reported shares beneficially owned:687,500 sharesPercent of class:7.74%Shares outstanding (basis):8,885,719 shares+1 more
4 metrics
Reported shares beneficially owned687,500 sharesReported on Schedule 13G by Rubric Capital and David Rosen
Percent of class7.74%Calculated using outstanding shares as of March 30, 2026
Shares outstanding (basis)8,885,719 sharesOutstanding as of March 30, 2026 per issuer proxy statement
Filing date / signaturesSigned 05/15/2026Schedule 13G signature dates for reporting persons
Key Terms
Schedule 13G, beneficially own, shared dispositive power
3 terms
Schedule 13Gregulatory
"This statement is filed by: Rubric Capital Management LP and David Rosen reported herein"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially ownfinancial
"Amount beneficially owned: The information required by Items 4(a) - (c) is set forth"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared dispositive powerfinancial
"Shared Dispositive Power 687,500.00 reported in cover rows"
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
EDESA BIOTECH, INC.
(Name of Issuer)
Common Shares, no par value
(Title of Class of Securities)
27966L306
(CUSIP Number)
03/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
27966L306
1
Names of Reporting Persons
Rubric Capital Management LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
687,500.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
687,500.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
687,500.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.74 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
27966L306
1
Names of Reporting Persons
David Rosen
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
687,500.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
687,500.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
687,500.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.74 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
EDESA BIOTECH, INC.
(b)
Address of issuer's principal executive offices:
100 Spy Court, Markham, A6 L3R 5H6
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Rubric Capital Management LP ("Rubric Capital"), the investment adviser to certain investment funds and/or accounts (collectively, the "Rubric Funds") that hold the Common Shares, no par value (the "Common Shares") of Edesa Biotech, Inc., a British Columbia, Canada corporation (the "Issuer") reported herein; and
(ii) David Rosen ("Mr. Rosen"), Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The filing of this statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Common Shares reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is 155 East 44th St, Suite 1630, New York, NY 10017.
(c)
Citizenship:
Rubric Capital is a Delaware limited partnership. Mr. Rosen is a citizen of the United States of America.
(d)
Title of class of securities:
Common Shares, no par value
(e)
CUSIP Number(s):
27966L306
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Items 4(a) - (c) is set forth in Rows 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentage set forth in Row (11) of the cover page for each of the Reporting Persons and in Item 4(b) is based on the 8,885,719 Common Shares outstanding as of March 30, 2026, as reported in the Issuer's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 3, 2026.
(b)
Percent of class:
7.74 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 2(a). Rubric Long Term Opportunities Offshore Master Fund, LP, a Rubric Fund, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of the Common Shares.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Rubric Capital and David Rosen report beneficial ownership of 687,500 shares representing 7.74% of Common Shares. This percentage uses 8,885,719 shares outstanding as of March 30, 2026 from the issuer's proxy statement.
Does the Schedule 13G say Rubric controls those EDSA shares?
The filing shows shared voting and dispositive power of 687,500 shares, not sole control. It lists Rubric as investment adviser to funds that hold the shares and shared authority over voting and disposition.
Is any fund named as having >5% economic interest in EDSA?
Yes. The filing identifies Rubric Long Term Opportunities Offshore Master Fund, LP as having the right to receive dividends or sale proceeds on more than 5% of the Common Shares.
What date is used to calculate the 7.74% ownership figure?
The percent is calculated using 8,885,719 Common Shares outstanding as of March 30, 2026, as reported in the issuer's Definitive Proxy Statement on Schedule 14A filed April 3, 2026.
Did the filing indicate any change in voting intent or plan to sell shares?
No. The Schedule 13G reports beneficial ownership and shared powers; it does not state any change in voting intent, planned sales, or an intent to influence control of the issuer.
